Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹4,580.00.
30 Oct: open ₹4,560.00, high ₹4,672.00, low ₹4,532.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,75,479 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.82%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,36,645
Torrent Pharmaceuticals share news and announcements
865 announcements, routine notices left out, newest first. Page 3 of 18.
Jul 2025
28 Jul · Meeting
28 Jul · Results
28 Jul · Board meeting
21 Jul · Analysts
7 Jul · General Updates
Jun 2025
30 Jun · Analysts
29 Jun · Board meeting
27 Jun · Updates
26 Jun
23 Jun · Updates
20 Jun
May 2025
20 May · Corporate action
20 May · Board meeting
20 May · Updates
20 May · Results
13 May · Analysts
11 May · Updates
Apr 2025
Mar 2025
26 Mar
26 Mar · Updates
25 Mar
19 Mar · Rating
Feb 2025
21 Feb · Analysts
17 Feb · Legal
14 Feb · Analysts
8 Feb · Analysts
7 Feb · Analysts
Jan 2025
24 Jan · Updates
24 Jan · Results
24 Jan · Results
15 Jan · Analysts
13 Jan · Corporate action
Dec 2024
26 Dec
19 Dec · Updates
Nov 2024
28 Nov · Legal
22 Nov
Oct 2024
25 Oct · Board meeting
25 Oct · Results
24 Oct · Rating